Accuray (NASDAQ: ARAY) and Orthofix International N.V. (NASDAQ:OFIX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, profitabiliy and valuation.


This table compares Accuray and Orthofix International N.V.’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Accuray -8.61% -61.49% -7.32%
Orthofix International N.V. -0.82% 10.03% 7.26%

Analyst Recommendations

This is a summary of recent ratings and price targets for Accuray and Orthofix International N.V., as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Accuray 0 3 3 0 2.50
Orthofix International N.V. 0 0 3 0 3.00

Accuray presently has a consensus price target of $7.40, indicating a potential upside of 70.11%. Orthofix International N.V. has a consensus price target of $51.83, indicating a potential upside of 15.67%. Given Accuray’s higher possible upside, equities analysts plainly believe Accuray is more favorable than Orthofix International N.V..

Volatility & Risk

Accuray has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500. Comparatively, Orthofix International N.V. has a beta of 0.33, meaning that its share price is 67% less volatile than the S&P 500.

Valuation & Earnings

This table compares Accuray and Orthofix International N.V.’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Accuray $366.29 million 0.99 -$5.10 million ($0.38) -11.45
Orthofix International N.V. $413.85 million 1.95 $48.07 million ($0.20) -224.05

Orthofix International N.V. has higher revenue and earnings than Accuray. Orthofix International N.V. is trading at a lower price-to-earnings ratio than Accuray, indicating that it is currently the more affordable of the two stocks.

Institutional & Insider Ownership

85.1% of Accuray shares are owned by institutional investors. Comparatively, 97.3% of Orthofix International N.V. shares are owned by institutional investors. 2.9% of Accuray shares are owned by insiders. Comparatively, 5.1% of Orthofix International N.V. shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.


Orthofix International N.V. beats Accuray on 10 of the 12 factors compared between the two stocks.

Accuray Company Profile

Accuray Incorporated is a radiation oncology company. The Company develops, manufactures and markets medical devices used in radiation therapy for the treatment of cancer patients. Its products include the CyberKnife Systems, the TomoTherapy Systems, and the Radixact Delivery Treatment Platform. Its technologies, the CyberKnife and TomoTherapy Systems, are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT) and adaptive radiation therapy. The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.

Orthofix International N.V. Company Profile

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim. The Biologics products include AlloQuent Structural Allografts, Trinity ELITE, Trinity Evolution and VersaShield. The Extremity Fixation products include Fixator, Eight-Plate Guided Growth System and Contours VPS Volar Plating System III. The Spine Fixation products include Hallmark Anterior Cervical Plate System, Ascent LE Posterior Occipital Cervico-Thoracic (POCT) System, Firebird Deformity Correction System, Phoenix Minimally Invasive Spinal Fixation System, Samba-Screw System, LONESTAR Cervical Stand Alone (CSA), SKYHAWK Lateral Interbody Fusion System & Lateral Plate System and CENTURION POCT System.

Receive News & Ratings for Accuray Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accuray Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.